United States · FDA National Drug Code directory
Osteopar
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44911-0711_aecc0eab-0618-415e-b035-8f971ecd453c
- Product NDC
- 44911-0711
- Form
- LIQUID
- Composition / generic term
- Equisetum Hyemale, Symphytum Officinale, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Medulla Ossis Suis, Oleum Morrhuae, Silicea, Hekla Lava
- Labeler
- Energique, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20240521
- Source listing expiry
- 20261231
Source-listed ingredients
- EQUISETUM HYEMALE WHOLE — 3 [hp_X]/mL
- COMFREY ROOT — 6 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE — 12 [hp_X]/mL
- CALCIUM FLUORIDE — 12 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE — 12 [hp_X]/mL
- SUS SCROFA BONE MARROW — 12 [hp_X]/mL
- COD LIVER OIL — 12 [hp_X]/mL
- SILICON DIOXIDE — 12 [hp_X]/mL
- HEKLA LAVA — 15 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (44911-0711-1) · 44911-0711-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →